申请人:——
公开号:US20040132724A1
公开(公告)日:2004-07-08
Compounds of formula (I) are modulators of STAT6 signal pathway activity, and can be used in the treatment of atopic dermatitis, urticaria, allergic asthma, allergic rhinitis, a food allergy, allergic conjunctivitis, hayfever, bullous pemphigoid, industrial sensitization, chronic rejection of transplants or COPD.
1
式(I)的化合物是STAT6信号通路活性的调节剂,并可用于治疗特应性皮炎、荨麻疹、过敏性哮喘、过敏性鼻炎、食物过敏、过敏性结膜炎、花粉症、天疱疮、工业致敏、移植物慢性排斥或COPD。